The Mounjaro Price Increase: What Actually Changed and What to Do Now

You saw the headlines. Here's what the numbers actually mean

Picture this: you've been on Mounjaro for a few months, the treatment is working, and then your inbox fills with news that the price has gone up sharply. That's the situation thousands of people in the UK found themselves in after Eli Lilly raised its list price on 1 September 2025. The most widely reported figure was the jump at the highest dose, from roughly £122 to around £330 per four-week pen. Lower doses moved by smaller amounts, though the full picture varied by dose and by which private provider you were looking at.

If you want to dig into exactly how different doses were affected, our breakdown of how the Mounjaro price increase worked across all doses covers the detail. For the 5mg pen specifically, there's a focused look at the Mounjaro 5mg price increase. And if you've seen claims that some doses didn't go up at all, it's worth reading what we know about the Mounjaro 2.5mg price situation before assuming yours is unaffected.

The short version: the increase was real, it was significant at the top end of the dose range, and private prices across the market reflect it. Reported pricing from a range of providers now sits roughly between £149 and £375 per month, depending on dose and service, hedged, because providers set their own margins on top of the list price. That range is sourced from widespread reporting and Lilly's own UK communications in August 2025.

Why the sticker price rarely tells the whole story

When you compare prices from different online pharmacies or weight-loss clinics, it's worth spending sixty seconds checking what each quote actually includes. Open the provider's website, find their pricing page, and look for a full itemised list. If you can't find one, that's already useful information.

Headline prices frequently exclude the consultation fee (which can run to £30–£50 at some services), a separate prescription charge, delivery costs, and ongoing aftercare or dose-review support. Add those up across a few months and the cheapest-looking option becomes considerably less cheap. This isn't a criticism of any specific provider, it's just how pricing is often structured, and it matters more when costs have already risen.

Tirzepatide (the active ingredient in Mounjaro) is a Prescription-Only Medicine. That means a qualified prescriber has to assess your suitability before anything is dispensed, that assessment has clinical value, and it has a real cost. Whether it shows on the invoice or gets absorbed into the headline price, it isn't free anywhere legitimate. Our full guide to Mounjaro pricing in the UK explains what a transparent all-in price should include, and what to ask any service before you commit.

What we charge at nume, and why we price the way we do

We are not the cheapest option on the market. That's a deliberate choice, not an oversight. One transparent price covers your consultation, your prescription, your treatment, and free next-working-day tracked delivery by DPD, plus priority aftercare from our clinical team seven days a week. There's no subscription pulling money out of your account each month, and every repeat order goes back to a real prescriber for review before it ships.

Our pharmacy is registered with the GPhC (premises registration 9012878, verifiable on the GPhC register), and every consultation is personally reviewed by a GPhC-registered Independent Prescriber, not an automated system. If you order by 12pm Monday to Friday and your prescription is clinically approved that day, your treatment goes out the same day. You can verify our standing on the register in less than a minute using that link.

Current treatment pricing is shown on our weight-loss treatments page. We don't publish per-pen prices in editorial copy because those numbers move, and we'd rather you see the accurate, current figure on the right page. What won't change is the structure: one price, nothing hidden, no renewal traps.

Why 'cheapest' is the wrong question when buying a prescription medicine

The price increase made a lot of people shop around, that's completely understandable. But for a Prescription-Only Medicine like Mounjaro, price is a poor proxy for value or safety. The MHRA has warned publicly about fake weight-loss pens circulating online; in October 2025, enforcement teams raided the UK's first illicit tirzepatide manufacturing site, and earlier actions seized what was reported as around 20 million doses of illegally traded weight-loss medicines worth roughly £45 million. Some counterfeit pens have contained insulin. The sellers in those cases weren't marketing themselves as illegal operations, many looked like ordinary pharmacies.

The safe checks are simple: a legitimate service will always require a prescription following a proper clinical assessment, and the dispensing pharmacy should be verifiable on the GPhC register. If you're wondering why the Mounjaro price increase happened in the first place, understanding the reasons behind it can also help you spot services offering prices that simply don't add up. You can report any suspect sellers directly through the MHRA's Yellow Card scheme.

If you'd like to explore what treatment at a properly regulated, clinician-led service actually looks like, our weight-loss treatment overview is a good place to start. And if you have specific questions before you begin, our FAQs page covers the most common ones, including whether any UK providers have kept their Mounjaro pricing unchanged since the list price rose. When you're ready, start your free consultation and a prescriber will assess your suitability the same day.